| Design, synthesis and biological evaluation of imidazo [2, 1-b] thiazole and benzo [d] imidazo [2, 1-b] thiazole derivatives as Mycobacterium tuberculosis pantothenate … G Samala, PB Devi, S Saxena, N Meda, P Yogeeswari, D Sriram Bioorganic & medicinal chemistry 24 (6), 1298-1307, 2016 | 62 | 2016 |
| Development of 3-phenyl-4, 5, 6, 7-tetrahydro-1H-pyrazolo [4, 3-c] pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors G Samala, PB Devi, R Nallangi, P Yogeeswari, D Sriram European journal of medicinal chemistry 69, 356-364, 2013 | 49 | 2013 |
| Development of novel tetrahydrothieno [2, 3-c] pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known … G Samala, PB Devi, R Nallangi, JP Sridevi, S Saxena, P Yogeeswari, ... Bioorganic & medicinal chemistry 22 (6), 1938-1947, 2014 | 48 | 2014 |
| Identification of novel inhibitors against Mycobacterium tuberculosis L-alanine dehydrogenase (MTB-AlaDH) through structure-based virtual screening S Saxena, PB Devi, V Soni, P Yogeeswari, D Sriram Journal of Molecular Graphics and Modelling 47, 37-43, 2014 | 44 | 2014 |
| Design and development of novel Mycobacterium tuberculosis L-alanine dehydrogenase inhibitors S Saxena, G Samala, JP Sridevi, PB Devi, P Yogeeswari, D Sriram European Journal of Medicinal Chemistry 92, 401-414, 2015 | 38 | 2015 |
| Identification and development of 2-methylimidazo [1, 2-a] pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors G Samala, R Nallangi, PB Devi, S Saxena, R Yadav, JP Sridevi, ... Bioorganic & Medicinal Chemistry 22 (15), 4223-4232, 2014 | 36 | 2014 |
| A review on DNA nanobots: A new techniques for cancer treatment U Devasena, P Brindha, R Thiruchelvi Asian J Pharm Clin Res 11 (6), 61-4, 2018 | 33 | 2018 |
| Structure‐Guided Design of Thiazolidine Derivatives as Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors PB Devi, G Samala, JP Sridevi, S Saxena, M Alvala, EG Salina, D Sriram, ... ChemMedChem 9 (11), 2538-2547, 2014 | 31 | 2014 |
| Development of 2-(4-oxoquinazolin-3 (4H)-yl) acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis GS Pedgaonkar, JP Sridevi, VU Jeankumar, S Saxena, PB Devi, ... European journal of medicinal chemistry 86, 613-627, 2014 | 30 | 2014 |
| Structure-guided design and development of novel benzimidazole class of compounds targeting DNA gyraseB enzyme of Staphylococcus aureus R Janupally, VU Jeankumar, KA Bobesh, V Soni, PB Devi, VK Pulla, ... Bioorganic & Medicinal Chemistry 22 (21), 5970-5987, 2014 | 28 | 2014 |
| Development of benzo [d] oxazol-2 (3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA GS Pedgaonkar, JP Sridevi, VU Jeankumar, S Saxena, PB Devi, ... Bioorganic & medicinal chemistry 22 (21), 6134-6145, 2014 | 18 | 2014 |
| Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities PB Devi, S Jogula, AP Reddy, S Saxena, JP Sridevi, D Sriram, ... Molecular Informatics 34 (2‐3), 147-159, 2015 | 17 | 2015 |
| Discovery of novel lysine ɛ-aminotransferase inhibitors: an intriguing potential target for latent tuberculosis PB Devi, JP Sridevi, SS Kakan, S Saxena, VU Jeankumar, V Soni, ... Tuberculosis 95 (6), 786-794, 2015 | 16 | 2015 |
| Design and Biological Evaluation of Furan/Pyrrole/Thiophene‐2‐carboxamide Derivatives as Efficient DNA GyraseB Inhibitors of Staphylococcus aureus R Janupally, B Medepi, P Brindha Devi, P Suryadevara, VU Jeankumar, ... Chemical Biology & Drug Design 86 (4), 918-925, 2015 | 16 | 2015 |
| Anti-tubercular activities of 5, 6, 7, 8-tetrahydrobenzo [4, 5] thieno [2, 3-d] pyrimidin-4-amine analogues endowed with high activity toward non-replicative Mycobacterium … G Samala, PB Devi, S Saxena, S Gunda, P Yogeeswari, D Sriram Bioorganic & medicinal chemistry 24 (21), 5556-5564, 2016 | 12 | 2016 |
| COVID-19-In silico structure prediction and molecular docking studies with doxycycline and quinine A Sumitha, PB Devi, S Hari, R Dhanasekaran Biomed. Pharmacol. J 13, 1185-1193, 2020 | 11 | 2020 |
| Computational sampling and simulation based assessment of novel Mycobacterium tuberculosis glutamine synthetase inhibitors: Study involving structure based drug design and free … P Suryadevara, P Yogeeswari, V Soni, P Brindha Devi, ... Current topics in medicinal chemistry 16 (9), 978-995, 2016 | 11 | 2016 |
| Investigating structure–activity relationship and mechanism of action of antitubercular 1-(4-chlorophenyl)-4-(4-hydroxy-3-methoxy-5-nitrobenzylidene) pyrazolidine-3, 5-dione [CD59] G Samala, SS Kakan, R Nallangi, PB Devi, JP Sridevi, S Saxena, ... International Journal of Mycobacteriology 3 (2), 117-126, 2014 | 10 | 2014 |
| Pharmacophoric Screening of Various Endophytic Fungal Metabolites EE Brindha Devi P, Rajagopal K Asian Journal of Pharmaceutical and Clinical Research 10 (5), 2017 | 9* | 2017 |
| Design and Development of Mycobacterium tuberculosis Lysine ɛ‐Aminotransferase Inhibitors for Latent Tuberculosis Infection BD Parthiban, S Saxena, M Chandran, PS Jonnalagadda, R Yadav, ... Chemical biology & drug design 87 (2), 265-274, 2016 | 9 | 2016 |
D SriramSenior Professor, Department of Pharmacy, BITS-Pilani, Hyderabad Campus在 hyderabad.bits-pilani.ac.in 的电子邮件经过验证
